[HTML][HTML] Adherence to post-exposure prophylaxis (PEP) and incidence of HIV seroconversion in a major North American cohort

…, C Galanakis, S Vézina, D Longpré, M Boissonnault… - PLoS …, 2015 - journals.plos.org
Background There is limited evidence on the efficacy of post-exposure prophylaxis (PEP)
for sexual exposures. We sought to determine the factors associated with adherence to …

Cohort profile: l'actuel pre-exposure prophylaxis (PrEP) cohort study in Montreal, Canada

…, J Szabo, JAB Robin, M Boissonnault… - BMJ open, 2019 - bmjopen.bmj.com
Purpose The l’Actuel PrEP Cohort was established to monitor the uptake, effectiveness,
safety and changes in sexual risk behaviours among individuals receiving pre-exposure …

Pre-Exposure prophylaxis uptake among men who have sex with men who used nPEP: a longitudinal analysis of attendees at a large sexual health clinic in Montréal …

…, RM Milwid, C Trottier, M Boissonnault… - JAIDS Journal of …, 2020 - journals.lww.com
Background: Reducing HIV transmission using pre-exposure prophylaxis (PrEP) requires
focussing on individuals at high acquisition risk, such as men who have sex with men with a …

Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study …

…, H Dion, S Vézina, S Lavoie, M Boissonnault… - HIV Clinical …, 2015 - Taylor & Francis
Background: Despite the benefit of maintaining inactive Nucleotide/side reverse transcriptase
inhibitors (NRTIs) in salvage regimens, they are associated with increased toxicity and …

Abacavir/lamivudine fixed-dose combination with ritonavir-boosted darunavir: a safe and efficacious regimen for HIV therapy

…, S Gallant, D Longpré, S Vézina, M Boissonnault… - HIV Clinical …, 2012 - Taylor & Francis
Background: Current treatment guidelines recommend the use of tenofovir (TDF) and
emtricitabine (FTC) along with a third agent to treat HIV-positive adults. However, other treatment …

High seroconversion rates following PrEP discontinuance in a Montreal Clinic

…, G Landry, A Hamel, M Boissonnault… - Journal of Virus …, 2018 - Elsevier
Materials and methods We aim to measure rates of temporary and permanent PrEP
discontinuations, describe stop reasons and measure seroconversion rates subsequent to stops …

Tolerability is more important than simplicity for treatment durability

…, S Lavoie, S Vezina, M Boissonnault… - Journal of the …, 2014 - search.proquest.com
Methods From our clinical database, we selected patients initiating any of the major first‐line
regimens between 2007 and 2013. Two STRs, Atripla (ATP) and Complera (CPLR), were …

Pre-exposure prophylaxis uptake among users of non-occupational post-exposure prophylaxis: a longitudinal analysis of attendees at a large sexual health clinic in …

…, RZ Greenwald, MR Milwid, C Trottier, M Boissonnault… - medRxiv, 2020 - medrxiv.org
Background Reducing HIV transmission using pre-exposure prophylaxis (PrEP) requires
targeting individuals at high acquisition risk, such as men who have sex with men (MSM) with a …

P3-S3. 08 Sensitivity and specificity of rapid HIV testing in a community setting

…, S Lavoie, D Longpré, M Boissonnault… - Sexually Transmitted …, 2011 - sti.bmj.com
Background It was estimated in 2005 that 13% of men who have sex with men (MSM) in
Montréal were HIV-positive, and that 23% of these were not aware of their diagnosis. Clinique …

P426 Risk factors associated with gonorrhea infection among PrEP patients in a montreal clinic

…, L Guibault, J Robin, G Landry, M Boissonnault… - 2019 - sti.bmj.com
Background Pre-exposure prophylaxis (PrEP) is effective for preventing HIV transmission.
Studies demonstrated high sexually transmitted infection (STI) incidence among men who …